General Information of This Metabolic Reaction (MR) (ID: MR006980)
Formula
Reactant 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol Product 20(S)-protopanaxadiol
Reactant Info Product Info
Metabolic Enzyme Unclear metabolic mechanism (DME-unclear) DME Info
Unclear metabolic mechanism (DME-unclear) DME Info
Unclear metabolic mechanism (DME-unclear) DME Info
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Produce The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR006333 Ginsenoside Re Metabolite Mc CK Unclear Ginsenoside Rc [1]
MR006456 Ginsenoside-F2 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol Unclear SC-46553 [2]
MR006979 Ginsenoside-F2 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol Unclear HY-N0040 [2]
Other MR(s) Related to The Product of This MR
Other MR(s) That Produce The Product of This MR
MR ID Reactant Product MR Type Related Drug REF
MR006351 Ginsenoside Rh2 20(S)-protopanaxadiol Unclear Ginsenoside Rh2 [3]
References
1 Pharmacokinetic study of ginsenoside Rc and simultaneous determination of its metabolites in rats using RRLC-Q-TOF-MS
2 Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria. Biol Pharm Bull. 2000 Dec;23(12):1481-5.
3 Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation--the key step of inflammation

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.